Skip to main content

Advertisement

Log in

Trends in antibiotic prescribing for adults in the United States—1995 to 2002

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

CONTEXT: The impact of national efforts to limit antibiotic prescribing has not been fully evaluated.

OBJECTIVES: To analyze trends in outpatient visits associated with antibiotic prescription for U.S. adults.

DESIGN: Cross-sectional study of data (1995 to 2002) from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey.

PARTICIPANTS: Adults ≥18 years with an outpatient visit to an office-or hospital-based medical practice or to an emergency department. All visits were classified into 1 of 4 diagnostic categories: (1) acute respiratory infection (ARI)—antibiotics rarely indicated, (2) ARI—antibiotics often indicated, (3) nonrespiratory infection—antibiotics often indicated, and (4) all others.

MEASUREMENTS: Trends in: (1) Proportion of outpatient visits associated with an antibiotic prescription; (2) proportion of antibiotic prescriptions that were broad spectrum; and (3) number of visits and antibiotic prescriptions per 1,000 U.S. adults ≥18 years of age.

RESULTS: From 1995–1996 to 2001–2002, the proportion of all outpatient visits that generated an antibiotic prescription decreased from 17.9% to 15.3% (adjusted odds ratio [OR] 0.84, 95% confidence interval [CI] 0.76 to 0.92). The entire reduction was because of a decrease in antibiotic prescriptions associated with visits for ARIs where antibiotics are rarely indicated from 59.9% to 49.1% (adjusted OR 0.64 95% CI 0.51 to 0.80). However, the proportion of prescribed antibiotics for these visits that were classified as broad-spectrum antibiotic prescription increased from 41.0% to 76.8%. Overall outpatient visits increased from 1693 to 1986 per 1,000 adults over the 8 years studied, but associated antibiotic prescriptions changed little, from 302 to 304 per 1,000 adults.

CONCLUSION: During the study period, outpatient antibiotic prescribing for respiratory infections where antibiotics are rarely indicated has declined, while the proportion of broad-spectrum antibiotics prescribed for these diagnoses has increased significantly. This trend resulted in a 15% decline in the total proportion of outpatient visits in which antibiotics were prescribed. However, because outpatient visits increased 17% over this time period, the population burden of outpatient antibiotic prescriptions changed little.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arroll B, Kenealy T. Antibiotics for the common cold. Cochrane Database Syst Rev. 2002;CD000247.

  2. Thomas MG, Arroll B. “Just say no”—reducing the use of antibiotics for colds, bronchitis and sinusitis. N Z Med J. 2000;113:287–9.

    PubMed  CAS  Google Scholar 

  3. McGowan JE Jr. Economic impact of antimicrobial resistance. Emer Infect Dis. 2001;7:286–92.

    Article  Google Scholar 

  4. Bertino JS. Cost burden of viral respiratory infections: issues for formulary decision makers. Am J Med. 2002;112(suppl 6A):42S-9S.

    Article  PubMed  Google Scholar 

  5. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214–9.

    Article  PubMed  CAS  Google Scholar 

  6. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901–4.

    Article  PubMed  CAS  Google Scholar 

  7. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719–25.

    Article  PubMed  Google Scholar 

  8. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991–1999. Ann Intern Med. 2003;138:525–33.

    PubMed  Google Scholar 

  9. Mainous AG III, Hueston WJ, Davis MP, Pearson WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health. 2003;93:1910–4.

    Article  PubMed  Google Scholar 

  10. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1–7.

    Article  PubMed  CAS  Google Scholar 

  11. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512–9.

    Article  PubMed  CAS  Google Scholar 

  12. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103–9.

    Article  PubMed  Google Scholar 

  13. Get smart know when antibiotics work. Centers for Disease Control and Prevention; Available at: http://www.cdc.gov/drugresistance/community/Accessed February 15, 2005.

  14. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med. 2001;134:487–9.

    PubMed  CAS  Google Scholar 

  15. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med. 2001;134:518–20.

    PubMed  CAS  Google Scholar 

  16. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001;134:521–9.

    PubMed  CAS  Google Scholar 

  17. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134:479–86.

    PubMed  CAS  Google Scholar 

  18. Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001;134:490–4.

    PubMed  CAS  Google Scholar 

  19. NAMCS. Available at: http://www.cdc.gov/nchs/about/major/ahcd/namcsds.htm. Accessed February 15, 2005.

  20. NHAMCS. Available at: http://www.cdc.gov/nchs/about/major/ahcd/nhamcsds.htm. Accessed February 15, 2005.

  21. US Population Estimates. Available at: http://www.census.gov/population/www/estimates/uspop.html. Accessed February 15, 2005.

  22. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Department of Health and Human Services; 1988.

  23. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. Chest. 2001;119:1185–9.

    Article  PubMed  CAS  Google Scholar 

  24. Peng CC, Aspinall SL, Good CB, Atwood CW Jr., Chang CC. Equal effectiveness of older traditional antibiotics and newer broad-spectrum antibiotics in treating patients with acute exacerbations of chronic bronchitis. South Med J. 2003;96:986–91.

    Article  PubMed  Google Scholar 

  25. Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000;117:1345–52.

    Article  PubMed  CAS  Google Scholar 

  26. Eltinge JL, Sribney WM. Estimates of linear combinations and hypothesis tests for survey data. Stata Tech Bull. 1996;31:31–42, 246–59.

    Google Scholar 

  27. Reed SD, Laxminarayan R, Black DJ, Sullivan SD. Economic issues and antibiotic resistance in the community. Ann Pharmacother. 2002;36:148–54.

    Article  PubMed  Google Scholar 

  28. Vogel RJ, Ramachandran S, Zachry WM. A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals. Clin Ther. 2003;25:309–29.

    Article  PubMed  Google Scholar 

  29. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescription in ambulatory care settings, United States, 1992–2000. Emerg Infect Dis. 2003;9:432–7.

    PubMed  Google Scholar 

  30. Halasa NB, Griffin MR, Zhu Y, Edwards KM. Decreased number of antibiotic prescriptions in office-based settings from 1993 to 1999 in children less than five years of age. Pediatr Infect Dis J. 2002;21:1023–8.

    Article  PubMed  Google Scholar 

  31. Finkelstein JA, Stille C, Nordin J, et al. Reduction in antibiotic use among US children, 1996–2000. Pediatrics. 2003;112(3 Part 1):620–7.

    Article  PubMed  Google Scholar 

  32. Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis. 1999;31:191–5.

    Article  PubMed  CAS  Google Scholar 

  33. O’Brien KL, Santosham M. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases. Am J Epidemiol. 2004;159:634–44.

    Article  PubMed  Google Scholar 

  34. Amsden GW. Pneumococcal resistance in perspective: how well are we combating it? Pediatr Infect Dis J. 2004;23(2 Suppl):S125–8.

    PubMed  Google Scholar 

  35. Jenson HB, Baltimore RS. Impact of pneumococcal and influenza vaccines on otitis media. Curr Opin Pediatr. 2004;16:58–60.

    Article  PubMed  Google Scholar 

  36. Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39:641–8.

    Article  PubMed  Google Scholar 

  37. Talbot TR, Poehling KA, Hartert TV, et al. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J. 2004;23:726–31.

    Article  PubMed  Google Scholar 

  38. Subcommittee on Otitis Media with Effusion. Clinical practice guideline from American Academy of Otolaryngology—Head and Neck Surgery and American Academy of Pediatics Subcommittee on Otitis Media with Effusion. Pediatrics. 2004;113:1412–29.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christianne L. Roumie MD, MPH.

Additional information

Dr. Edwards has received grants from Aventis, VaxGen, and GlaxoSmithKline. Dr. Griffin has consulted for Merck and received a grant from Pfizer.

This material is based upon work supported by the Veterans Affairs Clinical Research Center of Excellence (CRCoE)(C. L. R., M. R. G.).

Public Health Service award K12 RR017697 for the Vanderbilt Mentored Clinical Research Scholar Program (N. B. H.).

Vanderbilt Center for Education and Research Vanderbilt Center for Education and Research on Therapeutics, Vanderbilt University School of Medicine (M. R. G.).

Geriatric Research Education and Clinical Center, Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tenn (C. L. R., M. R. G., R. S. D.)

General Clinical Research Center, Vanderbilt University School of Medicine, Nashville, Tenn (K. M. E.).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roumie, C.L., Halasa, N.B., Grijalva, C.G. et al. Trends in antibiotic prescribing for adults in the United States—1995 to 2002. J Gen Intern Med 20, 697–702 (2005). https://doi.org/10.1111/j.1525-1497.2005.0148.x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1525-1497.2005.0148.x

Keywords

Navigation